메뉴 건너뛰기
International Journal of Rheumatic Diseases
Volumn 13, Issue 4, 2010, Pages
Subcutaneous methotrexate is well tolerated and superior to oral methotrexate in the treatment of rheumatoid arthritis
Author keywords

[No Author keywords available]
Indexed keywords

METHOTREXATE; RHEUMATOID FACTOR;
EID: 77958098216     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2010.01482.x     Document Type: Letter
Times cited : (20)
References (6)
  • 1
    • 1242297055 scopus 로고    scopus 로고
    • A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis
    • Jobanputra P, Wilson J, Douglas K, Burls A (2004) A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis. Rheumatology 43, 206-210.
    • (2004) Rheumatology , vol.43 , pp. 206-210
    • Jobanputra, P.1    Wilson, J.2    Douglas, K.3    Burls, A.4
  • 2
    • 34848839947 scopus 로고    scopus 로고
    • Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score
    • Van Der Kooij SM, De Vries-Bouwstra JK, Goekoop-Ruiterman YP, et al. (2007) Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score. Ann Rheum Dis 66, 1356-1362.
    • (2007) Ann Rheum Dis , vol.66 , pp. 1356-1362
    • Van Der Kooij, S.M.1    De Vries-Bouwstra, J.K.2    Goekoop-Ruiterman, Y.P.3
  • 3
    • 0027999764 scopus 로고
    • Methotrexate in rheumatoid arthritis, a five-year prospective multicenter study
    • Weinblatt ME, Kaplan H, Germain BF, et al. (1994) Methotrexate in rheumatoid arthritis, a five-year prospective multicenter study. Arthritis Rheum 37, 1492-1498.
    • (1994) Arthritis Rheum , vol.37 , pp. 1492-1498
    • Weinblatt, M.E.1    Kaplan, H.2    Germain, B.F.3
  • 4
    • 33244497852 scopus 로고    scopus 로고
    • Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis
    • Tilling L, Townsend S, David J (2006) Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis. Clin Drug Invest 26, 55-62.
    • (2006) Clin Drug Invest , vol.26 , pp. 55-62
    • Tilling, L.1    Townsend, S.2    David, J.3
  • 5
    • 67549101312 scopus 로고    scopus 로고
    • Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature
    • Visser K, Van Der Heijde D (2009) Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature. Annals of the Rheumatic Diseases 68, 1094-1099.
    • (2009) Annals of the Rheumatic Diseases , vol.68 , pp. 1094-1099
    • Visser, K.1    Van Der Heijde, D.2
  • 6
    • 38149057526 scopus 로고    scopus 로고
    • Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial
    • Braun J, Kästner P, Flaxenberg P, et al. (2008) Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial. Arthritis Rheum 58, 73-81.
    • (2008) Arthritis Rheum , vol.58 , pp. 73-81
    • Braun, J.1    Kästner, P.2    Flaxenberg, P.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.